Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2573.94 (Glytoucan)

Id:d9918fe3-f70b-513a-b759-2de6fb62b42a

Glytoucan:G91587RJ

Results found

Linked to

	Label	Description
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G41045CU-GLYCOSEQ00061303 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G75412QZ-GLYCOSEQ00006276 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G77113DB-GLYCOSEQ00076047 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G91587RJ-GLYCOSEQ00184987 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000076 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has motif 3-Sialyl-LN (type 2) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has canonical residue n-glycan b-d-galp 8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G60983SU-GLYCOSEQ00070251 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G38773BX-GLYCOSEQ00102891 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G41045CU-GLYCOSEQ00061303 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G75412QZ-GLYCOSEQ00006276 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G77113DB-GLYCOSEQ00076047 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G91587RJ-GLYCOSEQ00184987 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000076 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has motif 3-Sialyl-LN (type 2)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has canonical residue n-glycan b-d-galp 8

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G60983SU-GLYCOSEQ00070251 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2573.94 has glycosequence GLYGEN.GLYCOSEQUENCE:G38773BX-GLYCOSEQ00102891 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.